{"id":1308,"date":"2022-11-09T09:00:00","date_gmt":"2022-11-09T09:00:00","guid":{"rendered":"https:\/\/lee-pharm.com\/approval-of-a-drug-product-au409-manufactured-by-zhaoke-guangzhou-to-conduct-clinical-trial-in-the-united-states\/"},"modified":"2026-09-24T09:50:35","modified_gmt":"2026-09-24T09:50:35","slug":"approval-of-a-drug-product-au409-manufactured-by-zhaoke-guangzhou-to-conduct-clinical-trial-in-the-united-states","status":"publish","type":"post","link":"https:\/\/lee-pharm.com\/en\/approval-of-a-drug-product-au409-manufactured-by-zhaoke-guangzhou-to-conduct-clinical-trial-in-the-united-states\/","title":{"rendered":"Approval of a drug product AU409 manufactured by Zhaoke Guangzhou to conduct clinical trial in the United States"},"content":{"rendered":"<p>Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950) is pleased to announce that, on 26 October 2022, AU409, an investigational new drug candidate, drug product manufactured by Zhaoke Pharmaceutical (Guangzhou) Limited (\u201cZhaoke Guangzhou\u201d), a wholly-owned subsidiary of the Group, has been approved by the United States Food and Drug Administration (\u201cUS FDA\u201d) to conduct clinical trial in patients with advanced primary liver cancers or advanced solid tumor with liver predominant metastatic disease in the United States.<\/p>\n<p class=\"lpns-download-wrap\"><a class=\"lpns-download\" href=\"https:\/\/www.leespharm.com\/wp-content\/uploads\/2022\/11\/09.11.2022-Approval-of-a-drug-product-AU409-manufactured-by-Zhaoke-Guangzhou-to-conduct-clinical-trial-in-US.pdf\" target=\"_blank\" rel=\"noopener\">\u0e14\u0e32\u0e27\u0e19\u0e4c\u0e42\u0e2b\u0e25\u0e14\u0e02\u0e48\u0e32\u0e27\u0e09\u0e1a\u0e31\u0e1a\u0e40\u0e15\u0e47\u0e21 (PDF)<\/a><\/p>\n<p><em>\u0e17\u0e35\u0e48\u0e21\u0e32: <a href=\"https:\/\/www.leespharm.com\/media\/?filter=Recent\" target=\"_blank\" rel=\"noopener\">Lee&#8217;s Pharmaceutical Holdings \u2013 News &amp; Media<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950) is pleased to announce that, on 26 October 2022, AU409, an investigational new drug candidate, drug product manufactured by Zhaoke Pharmaceutical (Guangzhou) Limited (\u201cZhaoke Guangzhou\u201d), a wholly-owned subsidiary of the Group, has been approved by the United States Food and Drug Administration (\u201cUS FDA\u201d) to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1309,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,29],"tags":[],"class_list":["post-1308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lees-pharm-group-news","category-news"],"_links":{"self":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/comments?post=1308"}],"version-history":[{"count":1,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1308\/revisions"}],"predecessor-version":[{"id":1310,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1308\/revisions\/1310"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media\/1309"}],"wp:attachment":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media?parent=1308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/categories?post=1308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/tags?post=1308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}